Adaptimmune Therapeutics plc
ADAPNASDAQHealthcare
$0.05
$-0.00(-3.00%)
Market Cap$75157679
P/E Ratio—
52W High$0.86
52W Low$0.0202
Adaptimmune Therapeutics plc（ADAP）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ADAP · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.18B | $0.06B | $0.03B | $0.01B | $0.00B |
| Cost of Revenue | $0.00B | $0.01B | $0.13B | $0.11B | $0.09B |
| Gross Profit | $0.18B | $0.05B | ($0.10B) | ($0.10B) | ($0.09B) |
| Gross Margin %(computed) | 99.96% | 83.65% | -370.48% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.15B | $0.13B | $0.13B | $0.11B | $0.09B |
| G&A Expenses | $0.08B | $0.07B | $0.06B | $0.06B | $0.05B |
| Total Operating Expenses | $0.25B | $0.19B | $0.19B | $0.17B | $0.14B |
| Operating Income | ($0.07B) | ($0.14B) | ($0.16B) | ($0.16B) | ($0.13B) |
| Operating Margin %(computed) | -38.62% | -228.99% | -603.97% | — | — |
| Interest Income | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.07B) | ($0.11B) | ($0.16B) | ($0.16B) | ($0.13B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.07B) | ($0.11B) | ($0.17B) | ($0.16B) | ($0.13B) |
| Net Margin %(computed) | -39.78% | -188.90% | -609.46% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.28 | $-0.57 | $-1.02 | $-1.02 | $-0.90 |
| Wtd Avg Shares | 0.25B | 0.20B | 0.16B | 0.16B | 0.14B |
| EBITDA | ($0.05B) | ($0.13B) | ($0.16B) | ($0.16B) | ($0.13B) |
| EBITDA Margin %(computed) | -29.58% | -212.67% | -573.13% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Adaptimmune Therapeutics plc
关于Adaptimmune Therapeutics plc（ADAP）损益表
Adaptimmune Therapeutics plc（ADAP）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，ADAP实现营收$0.18B，毛利润$0.18B（毛利率99.96%），净利润($0.07B)（净利率-39.78%）。
常见问题
ADAP · 4 问Adaptimmune Therapeutics plc（ADAP）2024财年营收为$0.18B，同比up195.3%。
ADAP revenueADAP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08